Knowledge Center

White Paper / May 08, 2026

Integrated Nasal Powder Development Platform

Authors:
  • Claudia Costa
  • Dina Morais
Source:
Hovione White Paper

Why are nasal powders finally having their moment?

Nasal powder drug products are moving from niche to necessity. The intranasal route uniquely combines patient convenience, fast onset, and access to therapeutic spaces that are otherwise diffcult to reach, particularly the brain via olfactory and trigeminal pathways. 

Read the full white paper

 

 

Related links

Read the full white paper here

Also in the Knowledge Center

Related Content

Drug Substance Development

Hovione designs smarter, safer, and more efficient API processes—built on science, strengthened by data, enriched by experience, and ready for scale—helping you move faster, control complexity, and bring your product to market with confidence.

Page
Read more

Contact Us

Page
Read more

Speak Up!

An Ethics Line to enable team members to Speak Up!

Page
Read more